NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Pre-Clinical Research (R44)
| Jurisdiction: |
Federal
|
| Incentive Type: | Grant Program |
| Industries: |
Research, Health And Safety, Medical
|
| Eligible Sector: |
Business
|
| Category: |
Financial Incentive
|
| Time Period: |
FY 2015
|
| Governing Body: | National Institutes of Health |
| What’s it worth?: | Not mentioned |
The NINDS Renewal Awards of SBIR Phase II Grants for Pre-Clinical Research was developed to provide funding to further develop previously funded SBIR Phase II projects to commercialization and develop collaborative relationships between the NIH and third-party investors and strategic partners. Objectives of this application must include technical and commercial objectives that further the efforts of previously approved applications.
There are three types of applications allowed: New proposals (Phase I), Renewal grants (Phase II) and Resubmission applications. Typical award amounts of not more than $225,000 for Phase I projects and up to $1,500,000 for Phase II projects with project duration of up to two years. All applicants must meet the following criteria: